ArticleBioMed research international2022

PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.

Jufang Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.